Use of plan quality degradation to evaluate tradeoffs in delivery efficiency and clinical plan metrics arising from IMRT optimizer and sequencer compromises
Crossref DOI link: https://doi.org/10.1118/1.4808118
Published Online: 2013-06-10
Published Print: 2013-07
Update policy: https://doi.org/10.1063/aip-crossmark-policy-page
Wilkie, Joel R.
Matuszak, Martha M.
Feng, Mary
Moran, Jean M.
Fraass, Benedick A.
Funding for this research was provided by:
National Institutes of Health (P01‐CA‐59827)
National Institutes of Health (P01-CA-59827)
Version of Record valid from 2013-06-10
Text and Data Mining valid from 2015-09-01
